Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Reference ranges and biological variation of free and total serum indoxyl- and p-cresyl sulphate measured with a rapid UPLC fluorescence detection method.

Pretorius CJ, McWhinney BC, Sipinkoski B, Johnson LA, Rossi M, Campbell KL, Ungerer JP.

Clin Chim Acta. 2013 Apr 18;419:122-6. doi: 10.1016/j.cca.2013.02.008. Epub 2013 Feb 18. Review.


p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ, Tsai CJ, Tzen CY, Wang YC, Lin CY, Wu MS.

Nephrol Dial Transplant. 2011 Mar;26(3):938-47. doi: 10.1093/ndt/gfq580. Epub 2010 Sep 29.


Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.

Rossi M, Campbell K, Johnson D, Stanton T, Pascoe E, Hawley C, Dimeski G, McWhinney B, Ungerer J, Isbel N.

Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):1035-42. doi: 10.1016/j.numecd.2014.04.006. Epub 2014 May 4.


Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.

Rossi M, Johnson DW, Morrison M, Pascoe EM, Coombes JS, Forbes JM, Szeto CC, McWhinney BC, Ungerer JP, Campbell KL.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):223-31. doi: 10.2215/CJN.05240515. Epub 2016 Jan 15.


LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.

Shu C, Chen X, Xia T, Zhang F, Gao S, Chen W.

Biomed Chromatogr. 2016 Nov;30(11):1782-1788. doi: 10.1002/bmc.3753. Epub 2016 May 22.


Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients.

Rossi M, Johnson DW, Xu H, Carrero JJ, Pascoe E, French C, Campbell KL.

Nutr Metab Cardiovasc Dis. 2015 Sep;25(9):860-5. doi: 10.1016/j.numecd.2015.03.015. Epub 2015 Apr 9.


Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.

Lin CJ, Pan CF, Chuang CK, Liu HL, Sun FJ, Wang TJ, Chen HH, Wu CJ.

Arch Med Res. 2013 Oct;44(7):535-41. doi: 10.1016/j.arcmed.2013.09.007. Epub 2013 Sep 19.


Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.

Lin CJ, Wu V, Wu PC, Wu CJ.

PLoS One. 2015 Jul 14;10(7):e0132589. doi: 10.1371/journal.pone.0132589. eCollection 2015. Review.


Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis.

Lin CJ, Lin J, Pan CF, Chuang CK, Liu HL, Sun FJ, Wang TJ, Chen HH, Wu CJ.

Kidney Blood Press Res. 2015;40(2):121-9. doi: 10.1159/000368488. Epub 2015 Mar 19.


Uremic toxin development in living kidney donors: a longitudinal study.

Rossi M, Campbell KL, Johnson DW, Stanton T, Haluska BA, Hawley CM, Dimeski G, McWhinney BC, Ungerer JP, Kaisar OM, Isbel NM.

Transplantation. 2014 Mar 15;97(5):548-54. doi: 10.1097/


Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.

Wang CH, Cheng ML, Liu MH, Shiao MS, Hsu KH, Huang YY, Lin CC, Lin JF.

Heart Vessels. 2016 Jul;31(7):1100-8. doi: 10.1007/s00380-015-0702-0. Epub 2015 Jul 2.


Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography.

de Loor H, Meijers BK, Meyer TW, Bammens B, Verbeke K, Dehaen W, Evenepoel P.

J Chromatogr A. 2009 May 29;1216(22):4684-8. doi: 10.1016/j.chroma.2009.04.015. Epub 2009 Apr 14.


Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.

Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke HD, Wanner C, Canaud B.

Nephrol Dial Transplant. 2010 Jan;25(1):212-8. doi: 10.1093/ndt/gfp437. Epub 2009 Sep 15.


Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.

Viaene L, Meijers BK, Bammens B, Vanrenterghem Y, Evenepoel P.

Perit Dial Int. 2014 Jan-Feb;34(1):71-8. doi: 10.3747/pdi.2012.00276. Epub 2013 Oct 31. Erratum in: Perit Dial Int. 2015 Jul-Aug;35(4):492.


Removal of protein-bound uraemic toxins by haemodialysis.

Niwa T.

Blood Purif. 2013;35 Suppl 2:20-5. doi: 10.1159/000350843. Epub 2013 May 3. Review.


p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Meijers BK, De Loor H, Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P.

Clin J Am Soc Nephrol. 2009 Dec;4(12):1932-8. doi: 10.2215/CJN.02940509. Epub 2009 Oct 15.


The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.

Lin CJ, Pan CF, Liu HL, Chuang CK, Jayakumar T, Wang TJ, Chen HH, Wu CJ.

Atherosclerosis. 2012 Nov;225(1):173-9. doi: 10.1016/j.atherosclerosis.2012.07.012. Epub 2012 Aug 28.


Heritability and clinical determinants of serum indoxyl sulfate and p-cresyl sulfate, candidate biomarkers of the human microbiome enterotype.

Viaene L, Thijs L, Jin Y, Liu Y, Gu Y, Meijers B, Claes K, Staessen J, Evenepoel P.

PLoS One. 2014 May 21;9(5):e79682. doi: 10.1371/journal.pone.0079682. eCollection 2014.


The association of uremic toxins and inflammation in hemodialysis patients.

Hsu HJ, Yen CH, Wu IW, Hsu KH, Chen CK, Sun CY, Chou CC, Chen CY, Tsai CJ, Wu MS, Lee CC.

PLoS One. 2014 Jul 22;9(7):e102691. doi: 10.1371/journal.pone.0102691. eCollection 2014.


The Role of Liver in Determining Serum Colon-Derived Uremic Solutes.

Lin CJ, Liou TC, Pan CF, Wu PC, Sun FJ, Liu HL, Chen HH, Wu CJ.

PLoS One. 2015 Aug 10;10(8):e0134590. doi: 10.1371/journal.pone.0134590. eCollection 2015.

Supplemental Content

Support Center